Fact Based List:
Deborah L. Feinstein: Four design features of ACOs that raise red flags for antitrust agencies
Submitted by Charlene Ice on Fri, 07/25/2014 - 16:30
- preventing payers from steering patients to certain providers
- tying sales of the ACO’s services to the private payer’s purchase of other services from providers outside the ACO
- requiring exclusivity that discourages providers from contracting with payers outside the ACO
- restricting a payer’s ability to make available to enrollees information on cost, quality, efficiency, and performance
Notes: Deborah L. Feinstein is the Director of the Federal Trade Commission's Bureau of Competition. This list is from her presentation at the Fifth National ACO Summit.
Source: "Antitrust Enforcement in Health Care: Proscription, not Prescription," Fifth National Accountable Care Organization Summit – Washington, DC
Source URL: http://www.ftc.gov/system/files/documents/public_statements/...
List Ratings: |
Lists You Might Also Be Interested In
- Jacon C. Lee and Ken R. Steele: 14 Questions to Assess Your Organization's Readiness for Health Exchanges
- The State of ACOs at the start of Q3 2019: 8 things to know
- AJMC: Share of ACOs with Home-visit Initiatives That Offer 6 Services
- The 32 organizations participating in the Medicare Pioneer ACO Model
- Use of 9 Substance Use Disorder Treatment Resources by ACOs
Login or register to post comments